These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9859987)

  • 1. p53 polymorphism and risk of cervical cancer.
    Helland A; Langerød A; Johnsen H; Olsen AO; Skovlund E; Børresen-Dale AL
    Nature; 1998 Dec; 396(6711):530-1; author reply 532. PubMed ID: 9859987
    [No Abstract]   [Full Text] [Related]  

  • 2. Papillomavirus and p53.
    zur Hausen H
    Nature; 1998 May; 393(6682):217. PubMed ID: 9607756
    [No Abstract]   [Full Text] [Related]  

  • 3. p53 polymorphism and risk of cervical cancer.
    Josefsson AM; Magnusson PK; Ylitalo N; Quarforth-Tubbin P; Pontén J; Adami HO; Gyllensten UB
    Nature; 1998 Dec; 396(6711):531; author reply 532. PubMed ID: 9859988
    [No Abstract]   [Full Text] [Related]  

  • 4. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
    Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
    Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 polymorphism and risk of cervical cancer.
    Hildesheim A; Schiffman M; Brinton LA; Fraumeni JF; Herrero R; Bratti MC; Schwartz P; Mortel R; Barnes W; Greenberg M; McGowan L; Scott DR; Martin M; Herrera JE; Carrington M
    Nature; 1998 Dec; 396(6711):531-2. PubMed ID: 9859989
    [No Abstract]   [Full Text] [Related]  

  • 6. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development.
    Zehbe I; Voglino G; Wilander E; Delius H; Marongiu A; Edler L; Klimek F; Andersson S; Tommasino M
    Cancer Res; 2001 Jan; 61(2):608-11. PubMed ID: 11212257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.
    Storey A; Thomas M; Kalita A; Harwood C; Gardiol D; Mantovani F; Breuer J; Leigh IM; Matlashewski G; Banks L
    Nature; 1998 May; 393(6682):229-34. PubMed ID: 9607760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
    Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
    Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous arginine-72 in wild type p53 and risk of cervical cancer.
    Hayes VM; Hofstra RM; Buys CH; Hollema H; van der Zee AG
    Lancet; 1998 Nov; 352(9142):1756. PubMed ID: 9848359
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis.
    van Duin M; Snijders PJ; Vossen MT; Klaassen E; Voorhorst F; Verheijen RH; Helmerhorst TJ; Meijer CJ; Walboomers JM
    J Gen Virol; 2000 Feb; 81(Pt 2):317-25. PubMed ID: 10644829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer risk: is there a genetic component?
    Magnusson PK; Gyllensten UB
    Mol Med Today; 2000 Apr; 6(4):145-8. PubMed ID: 10740252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India.
    Pillai MR; Sreevidya S; Pollock BH; Jayaprakash PG; Herman B
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):627-31. PubMed ID: 12458344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women.
    Arbel-Alon S; Menczer J; Feldman N; Glezerman M; Yeremin L; Friedman E
    Int J Gynecol Cancer; 2002; 12(6):741-4. PubMed ID: 12445252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 polymorphism at codon 72--does it constitute a risk for squamous intraepithelial lesions and invasive cancer of the cervix in Central Europeans?
    Kucera E; Tong D; Reinthaller A; Leodolter S; Zeillinger R; Sliutz G
    Wien Klin Wochenschr; 2000 Sep; 112(18):817-20. PubMed ID: 11072671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polymorphism in codon 72 of the p53 gene and cervico-uterine cancer risk in Mexico].
    Suárez-Rincón AE; Morán-Moguel MC; Montoya-Fuentes H; Gallegos-Arreola MP; Sánchez-Corona J
    Ginecol Obstet Mex; 2002 Jul; 70():344-8. PubMed ID: 12221910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cellular and molecular pathogenesis of cancer of the cervix].
    Monsonego J
    Contracept Fertil Sex; 1995 Dec; 23(12):731-40. PubMed ID: 8556072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers.
    Szarka K; Veress G; Juhász A; Kónya J; Sápy T; Soós G; Hernádi Z; Gergely L
    Anticancer Res; 2000; 20(3B):2161-7. PubMed ID: 10928171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic susceptibility to HPV infection and cervical cancer.
    Maciag PC; Villa LL
    Braz J Med Biol Res; 1999 Jul; 32(7):915-22. PubMed ID: 10454752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV and cancer: the story unfolds.
    Campo MS
    Trends Microbiol; 1998 Nov; 6(11):424-6. PubMed ID: 9846352
    [No Abstract]   [Full Text] [Related]  

  • 20. Papillomavirus and p53 codon 72 polymorphism.
    Bertorelle R; Chieco-Bianchi L; Del Mistro A
    Int J Cancer; 1999 Aug; 82(4):616-7. PubMed ID: 10404080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.